![](/img/cover-not-exists.png)
A phase II trial of everolimus in patients with advanced pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy (NECTOR trial)
Okuyama, Hiroyuki, Ikeda, Masafumi, Okusaka, Takuji, Furukawa, Masayuki, Ohkawa, Shinichi, Hosokawa, Ayumu, Kojima, Yasushi, Hara, Hiroki, Murohisa, Gou, Shioji, Kazuhiko, Asagi, Akinori, Mizuno, NobuJournal:
Neuroendocrinology
DOI:
10.1159/000505550
Date:
January, 2020
File:
PDF, 207 KB
2020